SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011738
Filing Date
2021-05-17
Accepted
2021-05-17 13:15:00
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 783928
2 ex31-1.htm EX-31.1 10773
3 ex31-2.htm EX-31.2 10806
4 ex32-1.htm EX-32.1 4236
  Complete submission text file 0001493152-21-011738.txt   4241378

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE brtx-20210331.xml EX-101.INS 717605
6 XBRL SCHEMA FILE brtx-20210331.xsd EX-101.SCH 45474
7 XBRL CALCULATION FILE brtx-20210331_cal.xml EX-101.CAL 51976
8 XBRL DEFINITION FILE brtx-20210331_def.xml EX-101.DEF 189544
9 XBRL LABEL FILE brtx-20210331_lab.xml EX-101.LAB 356366
10 XBRL PRESENTATION FILE brtx-20210331_pre.xml EX-101.PRE 284771
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 21929144
SIC: 8090 Services-Misc Health & Allied Services, NEC